Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Melanoma antigen recognized by T-cells 1 (MART-1) (Antigen LB39-AA) (Antigen SK29-AA) (Protein Melan-A)

 MAR1_HUMAN              Reviewed;         118 AA.
Q16655; Q6ICU4;
01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
01-NOV-1996, sequence version 1.
27-SEP-2017, entry version 127.
RecName: Full=Melanoma antigen recognized by T-cells 1;
Short=MART-1;
AltName: Full=Antigen LB39-AA;
AltName: Full=Antigen SK29-AA;
AltName: Full=Protein Melan-A;
Name=MLANA; Synonyms=MART1;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Melanoma;
PubMed=8170938; DOI=10.1073/pnas.91.9.3515;
Kawakami Y., Eliyahu S., Delgado C.H., Robbins P.F., Rivoltini L.,
Topalian S.L., Miki T., Rosenberg S.A.;
"Cloning of the gene coding for a shared human melanoma antigen
recognized by autologous T cells infiltrating into tumor.";
Proc. Natl. Acad. Sci. U.S.A. 91:3515-3519(1994).
[2]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=8006593; DOI=10.1084/jem.180.1.35;
Coulie P.G., Brichard V., van Pel A., Woelfel T., Schneider J.,
Traversari C., Mattei S., de Plaen E., Lurquin C., Szikora J.-P.,
Renauld J.-C., Boon T.;
"A new gene coding for a differentiation antigen recognized by
autologous cytolytic T lymphocytes on HLA-A2 melanomas.";
J. Exp. Med. 180:35-42(1994).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Amygdala;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
"Cloning of human full open reading frames in Gateway(TM) system entry
vector (pDONR201).";
Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15164053; DOI=10.1038/nature02465;
Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
Rogers J., Dunham I.;
"DNA sequence and analysis of human chromosome 9.";
Nature 429:369-374(2004).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Skin;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[8]
SUBCELLULAR LOCATION.
PubMed=11551907; DOI=10.1074/jbc.M103221200;
Rimoldi D., Muehlethaler K., Salvi S., Valmori D., Romero P.,
Cerottini J.C., Levy F.;
"Subcellular localization of the melanoma-associated protein Melan-
AMART-1 influences the processing of its HLA-A2-restricted epitope.";
J. Biol. Chem. 276:43189-43196(2001).
[9]
SUBCELLULAR LOCATION.
PubMed=12191019; DOI=10.1034/j.1600-0854.2002.30909.x;
De Maziere A.M., Muehlethaler K., van Donselaar E., Salvi S.,
Davoust J., Cerottini J.-C., Levy F., Slot J.W., Rimoldi D.;
"The melanocytic protein Melan-A/MART-1 has a subcellular localization
distinct from typical melanosomal proteins.";
Traffic 3:678-693(2002).
[10]
FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH SILV.
PubMed=15695812; DOI=10.1074/jbc.M413692200;
Hoashi T., Watabe H., Muller J., Yamaguchi Y., Vieira W.D.,
Hearing V.J.;
"MART-1 is required for the function of the melanosomal matrix protein
PMEL17/GP100 and the maturation of melanosomes.";
J. Biol. Chem. 280:14006-14016(2005).
[11]
FUNCTION, AND INTERACTION WITH GPR143.
PubMed=19717472; DOI=10.1093/hmg/ddp415;
Giordano F., Bonetti C., Surace E.M., Marigo V., Raposo G.;
"The ocular albinism type 1 (OA1) G-protein-coupled receptor functions
with MART-1 at early stages of melanogenesis to control melanosome
identity and composition.";
Hum. Mol. Genet. 18:4530-4545(2009).
[12]
X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 100-114 IN COMPLEX WITH
HLA-DR1, AND PHOSPHORYLATION AT SER-108.
PubMed=20417641; DOI=10.1016/j.jmb.2010.04.037;
Li Y., Depontieu F.R., Sidney J., Salay T.M., Engelhard V.H.,
Hunt D.F., Sette A., Topalian S.L., Mariuzza R.A.;
"Structural basis for the presentation of tumor-associated MHC class
II-restricted phosphopeptides to CD4+ T cells.";
J. Mol. Biol. 399:596-603(2010).
-!- FUNCTION: Involved in melanosome biogenesis by ensuring the
stability of GPR143. Plays a vital role in the expression,
stability, trafficking, and processing of melanocyte protein PMEL,
which is critical to the formation of stage II melanosomes.
{ECO:0000269|PubMed:15695812, ECO:0000269|PubMed:19717472}.
-!- SUBUNIT: Interacts with PMEL. Interacts with GPR143.
{ECO:0000269|PubMed:15695812, ECO:0000269|PubMed:19717472,
ECO:0000269|PubMed:20417641}.
-!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
type III membrane protein. Golgi apparatus. Golgi apparatus,
trans-Golgi network membrane. Melanosome. Note=Also found in small
vesicles and tubules dispersed over the entire cytoplasm. A small
fraction of the protein is inserted into the membrane in an
inverted orientation. Inversion of membrane topology results in
the relocalization of the protein from a predominant Golgi/post-
Golgi area to the endoplasmic reticulum. Melanoma cells expressing
the protein with an inverted membrane topology are more
effectively recognized by specific cytolytic T-lymphocytes than
those expressing the protein in its native membrane orientation.
-!- TISSUE SPECIFICITY: Expression is restricted to melanoma and
melanocyte cell lines and retina.
-!- PTM: Acylated. {ECO:0000269|PubMed:12191019}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; U06452; AAA19238.1; -; mRNA.
EMBL; U06654; AAA20389.1; -; mRNA.
EMBL; CR450299; CAG29295.1; -; mRNA.
EMBL; AK312149; BAG35083.1; -; mRNA.
EMBL; AL365360; CAI95312.1; -; Genomic_DNA.
EMBL; CH471071; EAW58755.1; -; Genomic_DNA.
EMBL; CH471071; EAW58756.1; -; Genomic_DNA.
EMBL; BC014423; AAH14423.1; -; mRNA.
CCDS; CCDS6466.1; -.
PIR; A55253; A55253.
RefSeq; NP_005502.1; NM_005511.1.
UniGene; Hs.154069; -.
PDB; 2GT9; X-ray; 1.75 A; C/F=26-35.
PDB; 2GTW; X-ray; 1.55 A; C/F=27-35.
PDB; 2GTZ; X-ray; 1.70 A; C/F=27-35.
PDB; 2GUO; X-ray; 1.90 A; C/F=27-35.
PDB; 3HG1; X-ray; 3.00 A; C=26-35.
PDB; 3L6F; X-ray; 2.10 A; C=100-114.
PDB; 3MRO; X-ray; 2.35 A; P=26-35.
PDB; 3MRP; X-ray; 2.10 A; P=26-35.
PDB; 3MRQ; X-ray; 2.20 A; P=26-35.
PDB; 3QDM; X-ray; 2.80 A; C=26-35.
PDB; 3QEQ; X-ray; 2.59 A; C=27-35.
PDB; 3QFD; X-ray; 1.68 A; C/F=27-35.
PDB; 4EUP; X-ray; 2.88 A; C/F=27-35.
PDB; 4JFF; X-ray; 2.43 A; C=26-35.
PDB; 4L3E; X-ray; 2.56 A; C=26-35.
PDB; 4QOK; X-ray; 3.00 A; C=26-35.
PDB; 4WJ5; X-ray; 1.65 A; C/F=28-34.
PDB; 5E9D; X-ray; 2.51 A; C/H=26-35.
PDBsum; 2GT9; -.
PDBsum; 2GTW; -.
PDBsum; 2GTZ; -.
PDBsum; 2GUO; -.
PDBsum; 3HG1; -.
PDBsum; 3L6F; -.
PDBsum; 3MRO; -.
PDBsum; 3MRP; -.
PDBsum; 3MRQ; -.
PDBsum; 3QDM; -.
PDBsum; 3QEQ; -.
PDBsum; 3QFD; -.
PDBsum; 4EUP; -.
PDBsum; 4JFF; -.
PDBsum; 4L3E; -.
PDBsum; 4QOK; -.
PDBsum; 4WJ5; -.
PDBsum; 5E9D; -.
ProteinModelPortal; Q16655; -.
SMR; Q16655; -.
BioGrid; 108604; 2.
IntAct; Q16655; 4.
MINT; MINT-7889633; -.
STRING; 9606.ENSP00000370880; -.
iPTMnet; Q16655; -.
PhosphoSitePlus; Q16655; -.
BioMuta; MLANA; -.
DMDM; 2833278; -.
PaxDb; Q16655; -.
PeptideAtlas; Q16655; -.
PRIDE; Q16655; -.
DNASU; 2315; -.
Ensembl; ENST00000381471; ENSP00000370880; ENSG00000120215.
Ensembl; ENST00000381476; ENSP00000370885; ENSG00000120215.
Ensembl; ENST00000381477; ENSP00000370886; ENSG00000120215.
GeneID; 2315; -.
KEGG; hsa:2315; -.
UCSC; uc003zjo.2; human.
CTD; 2315; -.
DisGeNET; 2315; -.
EuPathDB; HostDB:ENSG00000120215.9; -.
GeneCards; MLANA; -.
HGNC; HGNC:7124; MLANA.
HPA; CAB000057; -.
HPA; HPA048662; -.
MIM; 605513; gene.
neXtProt; NX_Q16655; -.
OpenTargets; ENSG00000120215; -.
PharmGKB; PA30842; -.
eggNOG; ENOG410IZ4C; Eukaryota.
eggNOG; ENOG410ZDIV; LUCA.
GeneTree; ENSGT00390000009531; -.
HOGENOM; HOG000113481; -.
HOVERGEN; HBG006327; -.
InParanoid; Q16655; -.
KO; K17303; -.
OMA; MPRGDFN; -.
OrthoDB; EOG091G0Z8N; -.
PhylomeDB; Q16655; -.
TreeFam; TF338577; -.
ChiTaRS; MLANA; human.
EvolutionaryTrace; Q16655; -.
GeneWiki; MLANA; -.
GenomeRNAi; 2315; -.
PRO; PR:Q16655; -.
Proteomes; UP000005640; Chromosome 9.
Bgee; ENSG00000120215; -.
CleanEx; HS_MLANA; -.
Genevisible; Q16655; HS.
GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
GO; GO:0042470; C:melanosome; IDA:UniProtKB.
GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB.
InterPro; IPR029242; MLANA.
Pfam; PF14991; MLANA; 1.
1: Evidence at protein level;
3D-structure; Complete proteome; Endoplasmic reticulum;
Golgi apparatus; Membrane; Phosphoprotein; Reference proteome;
Transmembrane; Transmembrane helix.
CHAIN 1 118 Melanoma antigen recognized by T-cells 1.
/FTId=PRO_0000096238.
TRANSMEM 27 47 Helical. {ECO:0000255}.
TOPO_DOM 48 118 Cytoplasmic. {ECO:0000255}.
MOD_RES 108 108 Phosphoserine.
{ECO:0000269|PubMed:20417641}.
STRAND 29 31 {ECO:0000244|PDB:2GTW}.
SEQUENCE 118 AA; 13157 MW; B755BFF39CFCB16E CRC64;
MPREDAHFIY GYPKKGHGHS YTTAEEAAGI GILTVILGVL LLIGCWYCRR RNGYRALMDK
SLHVGTQCAL TRRCPQEGFD HRDSKVSLQE KNCEPVVPNA PPAYEKLSAE QSPPPYSP


Related products :

Catalog number Product name Quantity
E1097h ELISA Antigen LB39-AA,Antigen SK29-AA,Homo sapiens,Human,MART1,MART-1,Melanoma antigen recognized by T-cells 1,MLANA,Protein Melan-A 96T
E1097h ELISA kit Antigen LB39-AA,Antigen SK29-AA,Homo sapiens,Human,MART1,MART-1,Melanoma antigen recognized by T-cells 1,MLANA,Protein Melan-A 96T
U1097h CLIA Antigen LB39-AA,Antigen SK29-AA,Homo sapiens,Human,MART1,MART-1,Melanoma antigen recognized by T-cells 1,MLANA,Protein Melan-A 96T
M-0301 MART-1 (26-35) (human) Melanoma Antigen Recognized By T-Cells 1 (26-35) (human), Melan-A Protein (26-35) (human), Antigen LB39-AA (26-35) (human), Antigen SK29-AA (26-35) (human) 98 percent C42H74N 5mg
10-663-45593 MART-1 (MELAN-A) Protein Human - MART-1; Melan-A protein; Antigen SK29-AA; Antigen LB39-AA N_A 0.01 mg
10-663-45593 MART-1 (MELAN-A) Protein Human - MART-1; Melan-A protein; Antigen SK29-AA; Antigen LB39-AA N_A 0.005 mg
10-663-45593 MART-1 (MELAN-A) Protein Human - MART-1; Melan-A protein; Antigen SK29-AA; Antigen LB39-AA N_A 0.002 mg
15-288-21943 39S ribosomal protein L28. mitochondrial - L28mt; MRP-L28; Melanoma antigen p15; Melanoma-associated antigen recognized by T lymphocytes Polyclonal 0.1 mg
15-288-21943 39S ribosomal protein L28. mitochondrial - L28mt; MRP-L28; Melanoma antigen p15; Melanoma-associated antigen recognized by T lymphocytes Polyclonal 0.05 mg
10-288-21943F 39S ribosomal protein L28. mitochondrial - L28mt; MRP-L28; Melanoma antigen p15; Melanoma-associated antigen recognized by T lymphocytes 0.05 mg
10-288-21943F 39S ribosomal protein L28. mitochondrial - L28mt; MRP-L28; Melanoma antigen p15; Melanoma-associated antigen recognized by T lymphocytes 0.1 mg
EIAAB35258 39S ribosomal protein L28, mitochondrial,Homo sapiens,Human,L28mt,MAAT1,Melanoma antigen p15,Melanoma-associated antigen recognized by T lymphocytes,MRPL28,MRP-L28
YSRTMCA2207H Melan A, MART_1 (Melanoma Antigen Recognized by T_cells 1), Clone M2_7C10, Mab anti_Human; paraffin, IH 6 ml.
YSRTMCA2207 Melan A, MART_1 (Melanoma Antigen Recognized by T_cells 1), Clone M2_7C10, Mab anti_Human; paraffin, IH 1 ml.
ICCMMA Melan A, MART_1 (Melanoma Antigen Recognized by T_cells 1), 18kD, Clone cocktail M2_7C10 + M2_9E3, Mab anti_Human; frozen_paraffin, IH 1 ml.
EH1242 Melanoma antigen recognized by T-cells 1 Elisa Kit 96T
CSB-EL014618HU Human Melanoma antigen recognized by T-cells 1(MLANA) ELISA kit 96T
gen14843 MAR1_HUMAN Melanoma antigen recognized by T-cells 1 ELISA tesk kit 1
CSB-EL014618HU Human Melanoma antigen recognized by T-cells 1(MLANA) ELISA kit SpeciesHuman 96T
GWB-5A6C82 Melanoma Antigen Recognized By T-cells 1 (MLANA) Rabbit anti-Human Polyclonal Antibody
GWB-5B9BFB Melanoma Antigen Recognized By T-cells 1 (MLANA) Rabbit anti-Human Polyclonal (C-Terminus) (A19-P) Antibody
H-4102.0005 MART_1 (26_35) (human) Salt Trifluoroacetate Binding _ Synonym Melanoma Antigen Recognized By T_Cells 1 (26_35) (human), Melan_A Protein (26_35) (human), Antigen LB39_AA (26_35) (human), Antigen SK 5.0 mg
H-4102.0001 MART_1 (26_35) (human) Salt Trifluoroacetate Binding _ Synonym Melanoma Antigen Recognized By T_Cells 1 (26_35) (human), Melan_A Protein (26_35) (human), Antigen LB39_AA (26_35) (human), Antigen SK 1.0 mg
H-4102.0001 MART_1 (26_35) (human) Salt Trifluoroacetate Binding _ Synonym Melanoma Antigen Recognized By T_Cells 1 (26_35) (human), Melan_A Protein (26_35) (human), Antigen LB39_AA (26_35) (human), Antigen SK 1.0 mg
H-4102.0005 MART_1 (26_35) (human) Salt Trifluoroacetate Binding _ Synonym Melanoma Antigen Recognized By T_Cells 1 (26_35) (human), Melan_A Protein (26_35) (human), Antigen LB39_AA (26_35) (human), Antigen SK 5.0 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur